The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kalb Michael Wayne since 2018.
This trader's CIK number is 1678248.
At the time of last reporting, Kalb Michael Wayne was the Executive Vice President & CFO of Catalyst Pharmaceuticals, Inc.. (stock ticker symbol CPRX).
Also see all insider trading activities at Catalyst Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | AMRN | 0 | $0 | 0 | $0 | 124,600 | $0 |
| 2021 | AMRN | 0 | $0 | 120,000 | $630,240 | 306,453 | $308,400 |
| 2020 | AMRN | 0 | $0 | 0 | $0 | 150,236 | $0 |
| 2019 | AMRN | 0 | $0 | 450,000 | $8,215,050 | 480,000 | $1,047,750 |
| 2018 | AMRN | 0 | $0 | 150,000 | $1,565,550 | 179,000 | $328,500 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | CPRX | 0 | $0 | 0 | $0 | 6,894 | $0 |
2. Catalyst Pharmaceuticals, Inc. (CPRX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-07-29 | AMRN | Option Ex | 47,767 | .00 | 0 |
| 2022-02-28 | AMRN | Option Ex | 16,333 | .00 | 0 |
| 2022-01-31 | AMRN | Option Ex | 12,733 | .00 | 0 |
| 2021-12-31 | AMRN | Option Ex | 47,767 | .00 | 0 |
| 2021-08-31 | AMRN | Option Ex | 6,108 | .00 | 0 |
| 2021-08-12 | AMRN | Option Ex | 120,000 | 2.57 | 308,400 |
| 2021-08-12 | AMRN | Sale | 120,000 | 5.25 | 630,240 |
| 2021-07-30 | AMRN | Option Ex | 6,108 | .00 | 0 |
| 2021-06-30 | AMRN | Option Ex | 6,108 | .00 | 0 |
| 2021-04-30 | AMRN | Option Ex | 6,112 | .00 | 0 |
| 2021-03-31 | AMRN | Option Ex | 6,112 | .00 | 0 |
| 2021-02-25 | AMRN | Option Ex | 88,614 | .00 | 0 |
| 2021-02-26 | AMRN | Option Ex | 22,446 | .00 | 0 |
| 2021-01-29 | AMRN | Option Ex | 41,789 | .00 | 0 |
| 2020-12-31 | AMRN | Option Ex | 3,056 | .00 | 0 |
| 2020-11-30 | AMRN | Option Ex | 3,056 | .00 | 0 |
| 2020-10-30 | AMRN | Option Ex | 3,056 | .00 | 0 |
| 2020-09-30 | AMRN | Option Ex | 3,056 | .00 | 0 |
| 2020-08-31 | AMRN | Option Ex | 3,054 | .00 | 0 |
| 2020-07-31 | AMRN | Option Ex | 3,054 | .00 | 0 |
| 2020-06-30 | AMRN | Option Ex | 3,054 | .00 | 0 |
| 2020-05-29 | AMRN | Option Ex | 3,056 | .00 | 0 |
| 2020-04-30 | AMRN | Option Ex | 3,056 | .00 | 0 |
| 2020-03-31 | AMRN | Option Ex | 3,056 | .00 | 0 |
| 2020-02-28 | AMRN | Option Ex | 3,056 | .00 | 0 |
| 2020-02-25 | AMRN | Option Ex | 51,948 | .00 | 0 |
| 2020-01-31 | AMRN | Option Ex | 67,734 | .00 | 0 |
| 2019-12-16 | AMRN | Option Ex | 25,000 | 2.19 | 54,750 |
| 2019-12-16 | AMRN | Sale | 25,000 | 24.34 | 608,475 |
| 2019-07-01 | AMRN | Option Ex | 50,000 | 2.19 | 109,500 |
| 2019-07-01 | AMRN | Sale | 50,000 | 19.66 | 983,250 |
| 2019-03-01 | AMRN | Option Ex | 100,000 | 2.98 | 298,000 |
| 2019-03-01 | AMRN | Sale | 100,000 | 21.84 | 2,184,300 |
| 2019-02-22 | AMRN | Option Ex | 50,000 | 2.95 | 147,500 |
| 2019-02-22 | AMRN | Sale | 50,000 | 18.97 | 948,500 |
| 2019-02-15 | AMRN | Sale | 25,000 | 17.58 | 439,525 |
| 2019-01-31 | AMRN | Option Ex | 55,000 | .00 | 0 |
| 2019-01-09 | AMRN | Sale | 200,000 | 15.26 | 3,051,000 |
| 2019-01-09 | AMRN | Option Ex | 200,000 | 2.19 | 438,000 |
| 2018-09-24 | AMRN | Option Ex | 150,000 | 2.19 | 328,500 |
| 2018-09-24 | AMRN | Sale | 150,000 | 10.44 | 1,565,550 |
| 2018-01-31 | AMRN | Option Ex | 29,000 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-11-21 | CPRX | Option Ex | 6,894 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kalb Michael Wayne (Executive Vice President & CFO of Catalyst Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.